Table 4 Standardised incidence ratios (SIRs) and their 95% confidence intervals (CIs) for anal cancer among patients with anal fissure, fistula, or perianal abscess*.
| Fissure | Fistula | Perianal abscess | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Obs | SIR | 95% CI | Obs | SIR | 95% CI | Obs | SIR | 95% CI | |
| Overall | 5 | 3.9 | 1.3–9.2 | 2 | 1.3 | 0.2–4.9 | 6 | 5.3 | 1.9–11.5 |
| Sex | |||||||||
| Men | 2 | 4.7 | 0.6–16.9 | 1 | 1.3 | 0.03–7.4 | 1 | 1.6 | 0.04–9.0 |
| Women | 3 | 3.6 | 0.7–10.4 | 1 | 1.4 | 0.04–7.6 | 5 | 9.7 | 3.1–22.6 |
| Follow up duration (y) | |||||||||
| 3–9 | 3 | 5.9 | 1.2–17.3 | 0 | – | – | 4 | 7.1 | 1.9–18.3 |
| 10+ | 2 | 2.6 | 0.3–9.4 | 2 | 2.1 | 0.3–7.5 | 2 | 3.5 | 0.4–12.5 |
*Person years and anal cancer cases accrued during the first three years of follow‐up were excluded.
Obs, observed.